國立高雄大學圖資館 |

Language: English

Back

Applications of FDG PET in oncologyb...

Fujii, Hirofumi.

Applications of FDG PET in oncologybest clinical practice /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Applications of FDG PET in oncologyedited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda.
Reminder of title:	best clinical practice /
other author:	Fujii, Hirofumi.
Published:	Singapore :Springer Singapore :2021.
Description:	vii, 147 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Tomography, Emission.
Online resource:	https://doi.org/10.1007/978-981-15-8423-7
ISBN:	9789811584237$q(electronic bk.)

Applications of FDG PET in oncologybest clinical practice /
Applications of FDG PET in oncologybest clinical practice /[electronic resource] :edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda. - Singapore :Springer Singapore :2021. - vii, 147 p. :ill., digital ;24 cm.

1 Overview -- 2 Lung cancer -- 3 Breast cancer -- 4 Head and neck cancer -- 5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.

This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.

ISBN: 9789811584237$q(electronic bk.)

Standard No.: 10.1007/978-981-15-8423-7doiSubjects--Topical Terms:

276849
Tomography, Emission.

LC Class. No.: RC270.3.T65

Dewey Class. No.: 616.99407575

Applications of FDG PET in oncologybest clinical practice /
LDR:02437nmm a2200325 a 4500 001 596539
003 DE-He213
005 20201207124607.0
006 m d
007 cr nn 008maaau
008 211013s2021 si s 0 eng d
020 $a 9789811584237$q(electronic bk.)
020 $a 9789811584220$q(paper)
024 7 $a 10.1007/978-981-15-8423-7 $2 doi
035 $a 978-981-15-8423-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.3.T65
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99407575 $2 23
090 $a RC270.3.T65 $b A652 2021
245 0 0 $a Applications of FDG PET in oncology $h [electronic resource] : $b best clinical practice / $c edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a vii, 147 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1 Overview -- 2 Lung cancer -- 3 Breast cancer -- 4 Head and neck cancer -- 5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.
520 $a This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
650 0 $a Tomography, Emission. $3 276849
650 0 $a Cancer $x Tomography. $3 276848
650 1 4 $a Oncology. $3 195181
650 2 4 $a Imaging / Radiology. $3 274007
650 2 4 $a Cancer Research. $3 273660
700 1 $a Fujii, Hirofumi. $3 889377
700 1 $a Nakamura, Hiroyuki. $3 738248
700 1 $a Yasuda, Seiei. $3 889378
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-15-8423-7
950 $a Medicine (SpringerNature-11650)